Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes-Reference-Cited by-同舟云学术

Serum lactate dehydrogenase levels at presentation in stage IV non-small cell lung cancer: predictive value of metastases and relation to survival outcomes

Published:2015-08-04 Issue:1 Volume:37 Page:619-625
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

Lee Dong Soo,Park Kyung Ran,Kim Seung Joon,Chung Mi Joo,Lee Yun Hee,Chang Ji Hyun,Kang Jin Hyoung,Hong Sook Hee,Kim Myung Sin,Kim Yeon Sil

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-015-3776-5.pdf

Reference30 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

2. O'Connell JP, Kris MG, Gralla RJ, Groshen S, Trust A, Fiore JJ, et al. Frequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy. J Clin Oncol. 1986;4:1604–14.

3. Albain KS, Crowley JJ, LeBlanc M, Livingston RB. Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience. J Clin Oncol. 1991;9:1618–26.

4. Espinosa E, Feliu J, Zamora P, Gonzalez Baron M, Sanchez JJ, Ordon EZA, et al. Serum albumin and other prognostic factors related to response and survival in patients with advanced non-small cell lung cancer. Lung Cancer. 1995;12:67–76.

5. Hespanhol V, Queiroga H, Magalhaes A, Santos AR, Coelho M, Marques A. Survival predictors in advanced non-small cell lung cancer. Lung Cancer. 1995;13:253–67.

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum LDH and α-HBDH levels as biomarkers predicting the staging in lung adenocarcinoma patients;2024-05-15

2. Standardized uptake value_max of the primary lesion combined with tumor markers for clinically predicting distant metastasis in de novo lung adenocarcinoma;Cancer Medicine;2024-03-29

3. Prognostic Factors in Advanced Non-Small Cell Lung Cancer Patients Treated with Immunotherapy;Cancers;2023-09-22

4. The prognostic role of Gustave Roussy Immune Score (GRIm-Score) in metastatic lung adenocarcinoma patients treated with chemotherapy;Annals of Clinical and Analytical Medicine;2023-07-01

5. Gustave Roussy immune score is a prognostic marker in patients with small cell lung cancer undergoing immunotherapy: a real-world retrospective study;Frontiers in Oncology;2023-05-02